| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $58,947,412 ) (Continued on the next page) |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21CA290420 | Dietary fructose and NASH/HCC progression | 000 | 1 | NIH | 3/4/2024 | $219,491 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01CA278941 | Understanding Pancreatic Cancer Immune Microenvironment and Treatment Response through Integrating in vivo Imaging with Immunophenotyping | 000 | 1 | NIH | 3/8/2024 | $649,473 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01NS129987 | The role of SOCE in microglia and secondary degeneration after SCI | 001 | 2 | NIH | 5/14/2024 | $32,243 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01NS129987 | The role of SOCE in microglia and secondary degeneration after SCI | 000 | 2 | NIH | 12/18/2023 | $414,535 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AI168475 | 3D-bioprinting of sustained- and phased-release antibiotic and probiotic scaffolds to treat bacterial vaginosis | 001 | 3 | NIH | 5/23/2024 | $75,602 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AI168475 | 3D-bioprinting of sustained- and phased-release antibiotic and probiotic scaffolds to treat bacterial vaginosis | 000 | 3 | NIH | 1/22/2024 | $680,423 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | DP2MH136495 | Innovations in Personalizing Treatment for Eating Disorders Using Idiographic Methods and the Impact of Personalization on Psychological, Physical, and Sociodemographic Outcomes | 000 | 1 | NIH | 6/4/2024 | $266,772 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01EY035138 | Dissecting the role of aggrecan and perineuronal nets in visual plasticity | 000 | 2 | NIH | 6/21/2024 | $461,687 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01EY034092 | Cortical basis of binocular depth perception | 000 | 2 | NIH | 7/1/2024 | $384,631 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21AG080859 | 4D Flow MRI in Assessment of True Severe Low-Gradient Aortic Stenosis | 001 | 2 | NIH | 6/11/2024 | $195,625 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AI178106 | Impact of inflammatory lipids on Yersinia pestis infection | 000 | 2 | NIH | 6/6/2024 | $723,955 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | F31AA030934 | The role of MKP-1/MAPK in hepatocytes and macrophages in alcohol-associated liver disease pathogenesis | 000 | 2 | NIH | 5/8/2024 | $37,742 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01CA272772 | Identifying and targeting a novel mechanism of chemotherapy-induced immunotherapeutic resistance in non-small cell lung cancer | 001 | 2 | NIH | 4/17/2024 | $17,660 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01CA272772 | Identifying and targeting a novel mechanism of chemotherapy-induced immunotherapeutic resistance in non-small cell lung cancer | 000 | 2 | NIH | 3/12/2024 | $317,870 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL171763 | Cardiopulmonary Toxicity of Electronic Nicotine Delivery Systems | 000 | 1 | NIH | 12/14/2023 | $778,558 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01EY032645 | Preclinical evaluation of a homing endonuclease gene therapy for adRP in models of P23H retinopathy. | 000 | 2 | NIH | 3/11/2024 | $568,819 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21EY034674 | Detailed Molecular Structures of Tear Film Lipid Layer for Improved Treatment of Dry Eye Syndrome | 000 | 1 | NIH | 12/13/2023 | $216,825 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL168294 | Neuromodulatory rehabilitation for respiratory motor function in individuals with chronic spinal cord injury | 002 | 2 | NIH | 6/21/2024 | $30,096 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL168294 | Neuromodulatory rehabilitation for respiratory motor function in individuals with chronic spinal cord injury | 001 | 2 | NIH | 4/23/2024 | $338,570 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01CA279748 | Immunotherapeutic targeting of MIF-dependent chaperone activity | 001 | 2 | NIH | 4/16/2024 | $17,152 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01CA279748 | Immunotherapeutic targeting of MIF-dependent chaperone activity | 000 | 2 | NIH | 3/11/2024 | $308,690 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21CA277314 | A Stem Cell Based Exosomal Vaccine for the Prevention of Cancer | 001 | 2 | NIH | 4/16/2024 | $9,145 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21CA277314 | A Stem Cell Based Exosomal Vaccine for the Prevention of Cancer | 000 | 2 | NIH | 1/31/2024 | $164,619 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL168198 | Role of the PEP cycle in cardiac fibrosis | 000 | 1 | NIH | 11/17/2023 | $523,760 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01ES034389 | Role of Splenic Pro-Resolving Mediators During Exposure to Particulate Air Pollution | 000 | 2 | NIH | 2/14/2024 | $569,826 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21AA030638 | Role of urolithin A in progression of alcohol-associated liver disease | 001 | 2 | NIH | 5/20/2024 | $18,585 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21AA030638 | Role of urolithin A in progression of alcohol-associated liver disease | 000 | 2 | NIH | 2/26/2024 | $167,259 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R25GM148314 | University of Louisville Biomedical Integrative Opportunity for Mentored Experience Development -PREP (UL-BIOMED-PREP) | 001 | 2 | NIH | 6/19/2024 | $19,365 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R25GM148314 | University of Louisville Biomedical Integrative Opportunity for Mentored Experience Development -PREP (UL-BIOMED-PREP) | 000 | 2 | NIH | 2/9/2024 | $174,295 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R15CA274344 | The Role of HA Remodeling and Mesenchymal Transitions in Glioblastoma | 000 | 1 | NIH | 3/27/2024 | $469,500 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | H79SM084409 | Mental Health Awareness Training for Caregivers, Caring Adults, and Community Organizations to Recognize and Respond to Young People at Risk for Mental Health Problems | 003 | 2 | SAMHSA | 7/18/2024 | $125,000 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 300 East Market Street, Suite 300 | Louisville | KY | 40202-1959 | JEFFERSON | USA | T9449360 | Advanced Nursing Education Workforce | 00 | 2 | HRSA | 5/29/2024 | $646,605 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | M0142454 | Behavioral Health Workforce Education and Training Program | 00 | 4 | HRSA | 7/23/2024 | $500,000 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 300 East Market Street, Suite 300 | Louisville | KY | 40202-1959 | JEFFERSON | USA | U1Q53059 | Geriatrics Workforce Enhancement Program | 00 | 1 | HRSA | 5/23/2024 | $350,000 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 300 East Market Street, Suite 300 | Louisville | KY | 40202-1959 | JEFFERSON | USA | U1Q53059 | Geriatrics Workforce Enhancement Program | 00 | 1 | HRSA | 5/23/2024 | $650,000 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AI172873 | Neutrophil Heterogeneity and Immunopathogenesis of COVID-19 ARDS | 001 | 2 | NIH | 5/20/2024 | $57,409 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AI172873 | Neutrophil Heterogeneity and Immunopathogenesis of COVID-19 ARDS | 000 | 2 | NIH | 1/29/2024 | $516,695 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL163003 | Mechanisms Contributing to Pregnancy-induced Cardiac Remodeling | 001 | 2 | NIH | 6/8/2024 | $43,216 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL163003 | Mechanisms Contributing to Pregnancy-induced Cardiac Remodeling | 000 | 2 | NIH | 11/17/2023 | $486,191 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01EY035885 | The role of plasticity in loss of vision caused by retinitis pigmentosa | 000 | 1 | NIH | 12/12/2023 | $463,927 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | P20GM135004 | Center for Cancer Immunology and Immunotherapy (CCII) | 003 | 5 | NIH | 7/10/2024 | $0 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | P20GM135004 | Center for Cancer Immunology and Immunotherapy (CCII) | 001 | 5 | NIH | 5/15/2024 | $229,258 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | P20GM135004 | Center for Cancer Immunology and Immunotherapy (CCII) | 002 | 5 | NIH | 5/24/2024 | $947,067 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | P20GM135004 | Center for Cancer Immunology and Immunotherapy (CCII) | 000 | 5 | NIH | 1/25/2024 | $2,063,317 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01GM144349 | Linking the conformational landscape to enzymatic function through functional site distant mutations | 001 | 3 | NIH | 6/18/2024 | $32,428 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01GM144349 | Linking the conformational landscape to enzymatic function through functional site distant mutations | 000 | 3 | NIH | 12/12/2023 | $291,854 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL160927 | Fibroblast growth factor 1 prevents hyperlipidemia and atherosclerosis | 001 | 3 | NIH | 6/24/2024 | $43,408 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R34MH128213 | A Pilot Investigation of Network-Informed Personalized Treatment for Eating Disorders versus Enhanced Cognitive Behavioral Therapy and Dynamic Mechanisms of Change | 002 | 3 | NIH | 7/22/2024 | $23,475 |
| 2024 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL160927 | Fibroblast growth factor 1 prevents hyperlipidemia and atherosclerosis | 000 | 3 | NIH | 11/13/2023 | $488,331 |
|